KLRS insider buying
Every open-market purchase of Kalaris Therapeutics, Inc. (KLRS) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$6.18M
Insiders buying (12m)2
Purchases on record2
Last purchase filedMay 22, 2026
In the last 12 months, 2 insiders of Kalaris Therapeutics, Inc. bought $6.18M of KLRS stock on the open market in 2 reported purchases. The most recent was filed on May 22, 2026: Samsara BioCapital, L.P. +4 (10% Owner) bought 244,300 shares at $4.83, worth $1.18M. The largest purchase on record here is $5M by Samsara Opportunity Fund, L.P. +4 on Dec 18, 2025.
Get the next KLRS insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram